My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 154

    1.

    Utilities associated with diabetic retinopathy: results from a Canadian sample.

    Sharma S, Oliver-Fernandez A, Bakal J, Hollands H, Brown GC, Brown MM.

    Br J Ophthalmol. 2003 Mar;87(3):259-61.PMID: 12598432 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Utility values and diabetic retinopathy.

    Brown MM, Brown GC, Sharma S, Shah G.

    Am J Ophthalmol. 1999 Sep;128(3):324-30.PMID: 10511027 [PubMed - indexed for MEDLINE]Related articles

    3.

    Reliability of the time trade-off technique of utility assessment in patients with retinal disease.

    Hollands H, Lam M, Pater J, Albiani D, Brown GC, Brown M, Cruess AF, Sharma S.

    Can J Ophthalmol. 2001 Jun;36(4):202-9.PMID: 11428529 [PubMed - indexed for MEDLINE]Related articles

    4.

    Converting visual acuity to utilities.

    Sharma S, Brown GC, Brown MM, Shah GK, Snow K, Brown H, Hollands H.

    Can J Ophthalmol. 2000 Aug;35(5):267-72.PMID: 10959467 [PubMed - indexed for MEDLINE]Related articles

    5.

    Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients.

    Sharma S, Brown GC, Brown MM, Hollands H, Robins R, Shah GK.

    Br J Ophthalmol. 2002 May;86(5):493-6.PMID: 11973240 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration.

    Brown MM, Brown GC, Sharma S, Landy J, Bakal J.

    Arch Ophthalmol. 2002 Apr;120(4):481-4.PMID: 11934322 [PubMed - indexed for MEDLINE]Related articles

    7.

    TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.

    Shah VA, Gupta SK, Shah KV, Vinjamaram S, Chalam KV.

    Ophthalmic Epidemiol. 2004 Feb;11(1):43-51.PMID: 14977496 [PubMed - indexed for MEDLINE]Related articles

    8.

    The impact of anchor point on utilities for 5 common ophthalmic diseases.

    Lee BS, Kymes SM, Nease RF Jr, Sumner W, Siegfried CJ, Gordon MO.

    Ophthalmology. 2008 May;115(5):898-903.e4. Epub 2007 Sep 12.PMID: 17826833 [PubMed - indexed for MEDLINE]Related articles

    9.

    Health utility values associated with diabetic retinopathy.

    Lloyd A, Nafees B, Gavriel S, Rousculp MD, Boye KS, Ahmad A.

    Diabet Med. 2008 May;25(5):618-24. Epub 2008 Mar 13. Review.PMID: 18346157 [PubMed - indexed for MEDLINE]Related articles

    10.

    Vision and quality-of-life.

    Brown GC.

    Trans Am Ophthalmol Soc. 1999;97:473-511.PMID: 10703139 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy.

    Matza LS, Rousculp MD, Malley K, Boye KS, Oglesby A.

    Health Qual Life Outcomes. 2008 Nov 7;6:95.PMID: 18992161 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration.

    Brown GC, Brown MM, Sharma S.

    Can J Ophthalmol. 2000 Apr;35(3):127-33.PMID: 10812481 [PubMed - indexed for MEDLINE]Related articles

    13.

    Care of vision and ocular health in diabetic members of a national diabetes organization: a cross-sectional study.

    Sundling V, Gulbrandsen P, Jervell J, Straand J.

    BMC Health Serv Res. 2008 Jul 28;8:159.PMID: 18655733 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.

    Chew EY, Ferris FL 3rd, Csaky KG, Murphy RP, Agrón E, Thompson DJ, Reed GF, Schachat AP.

    Ophthalmology. 2003 Sep;110(9):1683-9.PMID: 13129862 [PubMed - indexed for MEDLINE]Related articles

    15.

    Vision-related quality of life in patients with diabetic macular oedema.

    Hariprasad SM, Mieler WF, Grassi M, Green JL, Jager RD, Miller L.

    Br J Ophthalmol. 2008 Jan;92(1):89-92. Epub 2007 Jun 21.PMID: 17584999 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden.

    Kobelt G, Jonsson B, Bergström A, Chen E, Lindén C, Alm A.

    Acta Ophthalmol Scand. 2006 Jun;84(3):363-71.PMID: 16704699 [PubMed - indexed for MEDLINE]Related articles

    17.

    Utility values among glaucoma patients: an impact on the quality of life.

    Gupta V, Srinivasan G, Mei SS, Gazzard G, Sihota R, Kapoor KS.

    Br J Ophthalmol. 2005 Oct;89(10):1241-4.PMID: 16170108 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Utility values and age-related macular degeneration.

    Brown GC, Sharma S, Brown MM, Kistler J.

    Arch Ophthalmol. 2000 Jan;118(1):47-51.PMID: 10636413 [PubMed - indexed for MEDLINE]Related articles

    19.

    Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states.

    Brown MM, Brown GC, Sharma S, Busbee B.

    Ophthalmology. 2003 Jun;110(6):1076-81.PMID: 12799229 [PubMed - indexed for MEDLINE]Related articles

    20.

    The impact of diabetic retinopathy on participation in daily living.

    Lamoureux EL, Hassell JB, Keeffe JE.

    Arch Ophthalmol. 2004 Jan;122(1):84-8.PMID: 14718300 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity